Back to search
FDAFDA · Food and drugs·Recall number D-0610-2017

Famciclovir tablets, 500 mg, packaged in 30-count unit dose cartons, Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-307-13

Published March 29, 2017 · Recall initiated: February 15, 2017

Summary

FDA records drug Class II recall D-0610-2017, published March 29, 2017 and initiated February 15, 2017. Recalling firm: AVKARE Inc.; Status: Terminated; Reported quantity: 116 cartons; Lot: Lot #15152, Exp. 02/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed impurities/ degradation specifications: Product was above specification for unknown impurities.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AVKARE Inc.
Distributor
Nationwide
Lot
Lot #15152, Exp. 02/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Famciclovir tablets, 500 mg, packaged in 30-count unit dose cartons, Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-307-13 recalled?

Yes. FDA published recall D-0610-2017 on March 29, 2017. Reported hazard: Failed impurities/ degradation specifications: Product was above specification for unknown impurities.

What should I do if I have this product?

Voluntary: Firm initiated · Letter